Skip to content
Simpler Grants

No. HT942526PCARPFPTA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Pancreatic Cancer Research Program, Focused Pilot Award

Dealbreakers No cost share required Audit: not stated
Not reimbursement-only
“The funding instrument for awards made under the program announcement will be grants (31 USC 6304).” — From the announcement
Award range
Not specified
Expected awards
~4
Application deadline
Oct 7, 2026
Posted
May 4, 2026
Last verified
2 days ago

At a glance

AI summary

This program funds innovative pancreatic cancer research focused on supportive care, quality of life, and survivorship. It can support clinical research studies and may include preliminary data, but it does not allow clinical trials or preclinical animal studies. Eligible applicants include extramural and intramural U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; investigators at any career level, including postdoctoral and clinical fellows, may be named PI. The award is a grant with a maximum period of 2 years and total costs capped at $0.3 million per award, and cost sharing is not required. The program expects to fund about four awards and notes no geographic restriction beyond eligibility tied to U.S. Department of War organizations.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data that can serve as a foundation for future clinical or real-world research application. Distinctive Features: This award mechanism allows, but does not require, preliminary data. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Preclinical animal studies do not meet the intent of this mechanism.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097
FY 2023 1,115
FY 2022 1,186
FY 2021 1,023

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026